2 September 2010

Kewill Systems

NO RECOMMENDATION

05/10/2001

Kewill's flagging share price received a much-needed boost on account of a positive trading update. Over the past 12 months the shares have slumped from a high of just over £10 to current levels, bottoming out at 30p in mid-September following a profit warning and the terrorist attacks on New York and Washington. The profit warning, which was delivered in August, saw supply-chain-management solutions business Kewill admit that sales in the first four months had been 'substantially below expectations' and that full year profitability was highly unlikely unless conditions dramatically improved. As a result of this statement broker forecasts were slashed. Market consensus had originally predicted that Kewill would continue to build on the success of last year, when pre-tax profits leapt 83% to £3.3m, with a profit in the region of £6.5m expected. Losses of around £5m are now being touted. Kewill's most recent update confirmed that first half figures are likely to be in line with these revised estimates, but stated that performance in the second quarter had shown a 'substantial improvement'. Although the dramatic improvement remains highly unlikely, management holds the belief that second half breakeven, at the operating level, is a distinct possibility.

Sector: Software & Computer Services

Companies: Kewill

Market cap: £32.1m

PE Forecast: n/a

Share price: 42p

Subscribe today


More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.

Subscribe today and save 50%

VCT Report 2010

VCT Report 2010 uncovers the money available

for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted

company.

Order VCT Report 2010 today using this online form

Cash Shells Directory 2010

A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.

Coverage of AIM, techMARK and PLUS Markets

Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.

Take control of your investments

A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.

The Financial Times Guide to Personal Tax

is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.

The AIM Guide Spring 2010

The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).

A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!

Share recommendations and small-cap stock picks

Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.

Popular Recommendations

Latest Recommendations

Delcam 01/09/2010

Delcam, the international seller of CAD/CAM software to the engineering, aerospace and healthcare sectors among others, is a cash-generative small-cap seeing recovery in its markets.

Antisoma 01/09/2010

Bombed-out biotech play Antisoma is hoping two of its drugs will lead to good fortune after experiencing disaster with lung cancer treatment ASA404.

GW Pharmaceuticals 31/08/2010

GW Pharmaceuticals has won approval from Health Canada for its cannabis-based Sativex product to treat spasticity caused by Multiple Sclerosis.

More Recommendations

Sectors

Vitesse Media Events